Clinical Trial Update: NCI COVID-19 in Cancer Patients, NCCAPS Study

View source ↗

Summary

A National Cancer Institute study (NCT04387656) evaluating COVID-19 infection in cancer patients is ongoing, with the trial status currently ACTIVE_NOT_RECRUITI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Infection
• Hematologic Malignancies
• Malignant Solid Neoplasms
• Solid Malignant Neoplasms

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: COVID-19 Infection, Hematopoietic and Lymphatic System Neoplasm | Status: ACTIVE_NOT_RECRUITING